In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 + T H 1 cell response

Author:

Sutra Del Galy Aurélien1ORCID,Menegatti Silvia2ORCID,Fuentealba Jaime2,Lucibello Francesca2,Perrin Laetitia2,Helft Julie2ORCID,Darbois Aurélie2,Saitakis Michael2ORCID,Tosello Jimena2ORCID,Rookhuizen Derek2,Deloger Marc3ORCID,Gestraud Pierre4ORCID,Socié Gérard1ORCID,Amigorena Sebastian2ORCID,Lantz Olivier256ORCID,Menger Laurie2ORCID

Affiliation:

1. AP-HP Hospital Saint Louis, Hematology/Transplantation, Paris 75010, France.

2. INSERM U932, PSL University, Institut Curie, Paris 75005, France.

3. INSERM US23, CNRS UMS 3655, Gustave Roussy Cancer Campus, 94800 Villejuif, France.

4. Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, MINES ParisTech, INSERM U900, Paris 75005, France.

5. Laboratoire d’immunologie clinique, Institut Curie, Paris 75005, France.

6. Centre d’investigation Clinique en Biothérapie Gustave-Roussy Institut Curie (CIC-BT1428), Institut Curie, Paris 75005, France.

Abstract

Inactivation of SOCS1 optimizes adoptive T cell therapy including human CAR-T cell composition and efficacy.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3